Ornithine Carbamoyltransferase Deficiency Disease
📧 Sign up to get email alerts when something new happens for Ornithine Carbamoyltransferase Deficiency Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2022-12-16EMA Authorised: Ammonaps (sodium phenylbutyrate) — Immedica Pharma AB
EMA authorised Ammonaps (sodium phenylbutyrate) for OTCD, citrullinemia, and CPS1 deficiency conditions.